Revolution? What revolution?

Revolution? What revolution?

Build it and they will come. They didn't. COVID did. And they left again.

This newsletter brings fresh insight into how technological innovation (and investment) alone will not bring the [much hyped] revolution..

The 'Digital Health. Revolution?!?' newsletter will publish NEW RESEARCH and analysis, detailing the perspectives of multiple global stakeholders. Identifying the drivers and barriers to adoption of digital health solutions.

Bryter Health and Pharma is a global insights consultancy working in biopharma and consumer technology. Focused on human needs and behavioral change. Bryter has researched the intersection of healthcare and technology from its foundation in 2010.

We have been studying the impact of the pandemic on the acceptance and usage of digital health globally.

Using a combination of advanced analytics and behavioral science frameworks, to derive new insight from over 25,000 primary research interviews conducted with:-

No alt text provided for this image
Bryter's Primary Research - Overview

  • Healthcare Professionals
  • Consumers
  • Patients/caregivers
  • Health system leaders
  • Life science professionals

Assessing from multiple viewpoints, how usage, attitudes and [digital health] behaviors have changed (if at all) following the pandemic, and as technology and products have advanced from 'tracking' to intervention, management and treating disease through digital therapeutics (DTx).

And WHY?

The 'Digital Health Revolution?!?' Newsletter

Over the coming weeks, we will publish the findings from NEW RESEARCH that will:-

  1. Demonstrate how digital health tools are used globally
  2. Evaluate (debunk) the true extent of consumer/patient health data concerns as a barrier to adoption
  3. Assess the role of pharma vs. specialized digital health / therapeutic developers in bringing products to market
  4. Segment consumer, provider and life science professionals attitudes to technology and its role in healthcare provision
  5. Identify how a lack of category understanding and communication of product benefits to needs across consumer / HCP stakeholders is a MAJOR barrier the realization of digital health potential





要查看或添加评论,请登录

Bryter Health and Pharma的更多文章

社区洞察

其他会员也浏览了